The MeCP2 mutationsidentified in patients with Rett syndrome include, among others, pointmutations causing MeCP2 degradation but not affecting the structure of itsDNA-binding and repressor domains [126]. This evidence concerns the gene MECP2 and atypical Rett syndrome.